Peptron, Inc. (KOSDAQ:087010)

South Korea flag South Korea · Delayed Price · Currency is KRW
270,500
-12,500 (-4.42%)
Apr 28, 2026, 3:30 PM KST
55.10%
Market Cap 6.31T
Revenue (ttm) 5.63B
Net Income (ttm) -13.82B
Shares Out 23.32M
EPS (ttm) -595.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 120,636
Average Volume 126,272
Open 279,500
Previous Close 283,000
Day's Range 270,000 - 280,000
52-Week Range 151,000 - 392,500
Beta 0.75
RSI 48.04
Earnings Date n/a

About Peptron

Peptron, Inc. engages in the development of peptide-based medicines. The company’s technologies include long acting; and SmartDepot, an ultrasonic spray drying technology for the preparation of sustained release injectable microsphere formulation of drug. It develops PAb 001 for cancer therapy; SR-Exenatide (PT320) for Parkinson’s and other neurodegenerative disease; SR-Octreotide for the treatment of acromegaly; and Dernak filler for bioequivalence. Peptron, Inc. was founded in 1997 and is headquartered in Daejeon, South Korea. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1997
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 087010
Full Company Profile

Financial Performance

In 2025, Peptron's revenue was 5.63 billion, an increase of 78.76% compared to the previous year's 3.15 billion. Losses were -13.82 billion, -37.26% less than in 2024.

Financial Statements

News

There is no news available yet.